Supaveda · Ingredient Spotlight
Brahmi
Bacopa monnieri (L.) Wettst.
Also known as: Water Hyssop · Herb of Grace · Thyme-leaved Gratiola · Jalabrahmi
Brahmi (Bacopa monnieri) is Ayurveda's foremost herb for the mind — a small, creeping wetland plant whose Sanskrit name connects it to Brahman, the Hindu concept of universal consciousness. For over three thousand years, it has been prescribed by Ayurvedic physicians for memory, learning, and mental clarity. Today, it is one of the most rigorously studied herbs in modern neuroscience.
A creeping perennial found in wetlands and marshes throughout India, Sri Lanka, Nepal, China, and Australia, B. monnieri has been described as a Medhya Rasayana — a rejuvenative tonic for the intellect — in both the Charaka Samhita and the Sushruta Samhita. Its use has been documented for the treatment of epilepsy, anxiety, poor memory, and nervous disorders for millennia. 1 More than 300 peer-reviewed studies now exist on its pharmacology, with over 20 randomised controlled trials in human subjects assessing its effects on cognition.
A Note on the Name "Brahmi"
The name Brahmi is used for two different plants across India, which can cause confusion. In North India and in standard Ayurvedic references, Brahmi = Bacopa monnieri. In South India, Brahmi is sometimes used to refer to Centella asiatica (Gotu Kola). Both are Medhya Rasayana herbs and are sometimes prescribed together as a synergistic cognitive pair — as in our SupaMind blend. This blog covers Bacopa monnieri specifically. For Centella asiatica, see our Gotu Kola ingredient blog.
At a Glance — Key Evidence-Backed Benefits
Traditional Ayurvedic Uses
Brahmi's place in Ayurvedic medicine is unambiguous and long-established. Both the Charaka Samhita and Sushruta Samhita describe Brahmi as a preeminent Medhya Rasayana — a herb that specifically rejuvenates and enhances the mind (medhya = intellect; rasayana = rejuvenating tonic). The classical texts recommend it for enhancing memory, intelligence, and speech, and as a treatment for epilepsy (Apasmara), anxiety (Manasa Roga), and insomnia. 1 The name Brahmi itself — derived from Brahman — encodes the ancient belief that this herb elevates the mind toward its highest capacity for clarity and understanding.
Ayurvedic Properties (Guna)
Conditions Traditionally Treated
- Poor memory, impaired learning, and reduced intellectual capacity — the herb's primary classical use
- Epilepsy and convulsions (Apasmara) — used in medicated ghee preparations and smoke inhalation
- Anxiety, mental restlessness, and stress-related disorders (Manasa Roga)
- Insomnia and disturbed sleep — Brahmi's cooling and calming nature makes it a classical sleep support
- Speech disorders — combined with Vacha for this purpose in classical formulas
- Skin diseases and wound healing — applied topically as a paste
- Anaemia, fever, and general debility as a Rasayana tonic
How It Was Traditionally Administered
The classical preparation most closely associated with Brahmi's cognitive effects is Brahmi Ghrita — the herb cooked into clarified butter — which was administered with warm milk for both children and adults seeking to enhance memory and learning. This fat-based delivery is now understood to be pharmacologically intelligent: the fat-soluble bacosides are better absorbed when taken with lipids. The fresh leaf juice (swarasa) was also applied directly, and the dried powder was given with honey. In classical compound preparations, Brahmi was most often combined with Vacha (Acorus calamus) and Shankhpushpi — the same trio that forms the basis of our SupaMind formula.
Key Active Compounds
The pharmacological activity of B. monnieri is attributed primarily to its triterpenoid saponins — collectively known as bacosides — which are considered the herb's principal active constituents. 12 Bacoside A and Bacoside B were first isolated in the 1980s; subsequent research has identified an extended family of bacosides and bacopasides, along with alkaloids, flavonoids, and other phytochemicals.
Primary Bioactive Constituents
How It Works: The Neuroscience of Brahmi
Brahmi's cognitive effects arise from a remarkably broad set of neurological mechanisms — which may explain why its benefits appear consistent across multiple cognitive domains rather than being limited to one specific pathway. A comprehensive 2013 neuropharmacological review in Rejuvenation Research synthesised the known mechanisms. 3
Key Neurological Mechanisms — Confirmed Preclinically & in Human Trials
This multi-target profile — simultaneously supporting neurotransmitter availability, neuronal repair, antioxidant defence, and cerebral blood flow — is characteristic of a true Rasayana as described in Ayurveda: a herb that restores underlying physiological balance rather than acting on a single pathway. 3
What the Research Says
Brahmi has one of the strongest clinical evidence bases among all Ayurvedic herbs for cognitive support, with over 20 randomised controlled trials (RCTs) and multiple systematic reviews. A 2024 systematic review published in Antioxidants (MDPI) identified 22 human clinical trials showing benefits across memory, cognition, anxiety, sleep, and emotional function. 4 A landmark meta-analysis in the Journal of Ethnopharmacology (2014) pooled the RCT data and confirmed significant improvements in speed of attention. 5
The most consistently demonstrated clinical effect of Brahmi is improvement in memory consolidation — the brain's ability to retain newly learned information over time. A foundational double-blind, placebo-controlled RCT published in Psychopharmacology (Stough et al., 2001) administered 300 mg/day of B. monnieri extract to 46 healthy adults over 12 weeks. The Brahmi group showed statistically significant improvements in learning rate and memory consolidation measured by the Auditory Verbal Learning Test (AVLT), and in speed of visual information processing, compared to placebo. 6 A separate double-blind RCT in older adults by Morgan and Stevens (2010) confirmed significant improvements in memory score on the Rey Auditory Verbal Learning Test (RAVLT) after 12 weeks at 300 mg/day. 7
Brahmi has been specifically described in the clinical literature as a "calming cognitive enhancer" — uniquely improving cognitive performance while simultaneously reducing anxiety, unlike most stimulant-based cognitive enhancers. 2 A randomised, double-blind, placebo-controlled RCT by Calabrese et al. (2008) published in the Journal of Alternative and Complementary Medicine administered standardised Brahmi extract to 54 adults aged 65 and over. Over 12 weeks, the Brahmi group showed significantly reduced anxiety and depression scores alongside improvements in cognitive performance, with no adverse effects — a result of particular relevance for older populations. 8 The anxiolytic mechanism is attributed to modulation of serotonin (5-HT3) receptors, GABA-ergic activity from the flavonoid apigenin, and cortisol reduction via HPA axis modulation. 3
The 2024 systematic review in Antioxidants (MDPI) provides the most comprehensive synthesis of Brahmi's neuroprotective evidence. Across 22 included clinical trials, Brahmi was shown to reduce NF-κB phosphorylation (a key inflammatory marker in neurodegeneration), improve emotional function in Parkinson's disease patients, improve memory retention and cognitive functions across age groups, reduce anhedonia, and improve sleep. 4 Preclinically, bacosides have been shown to reduce β-amyloid accumulation in Alzheimer's models, protect against mitochondrial dysfunction, and reduce tau phosphorylation — three of the core pathological processes in Alzheimer's disease. While these findings require clinical validation in human neurodegenerative populations, the 2022 systematic review in Interactive Journal of Medical Research reviewed five RCTs specifically in Alzheimer's disease and found cognitive benefit signals, though with small sample sizes. 9
A rigorous double-blind, placebo-controlled RCT published in Phytotherapy Research (Kean et al., 2022) evaluated the effects of Brahmi extract (CDRI 08, 225 mg/day) in 125 boys aged 6–14 years exhibiting inattention and hyperactivity over a 24-week period. The Brahmi group showed significant improvements in cognitive performance compared to placebo, with the authors noting adequate sample size and methodological quality. 10 Earlier open-label studies in children with attention difficulties also demonstrated improvements in memory, learning, and academic performance. These findings align with Ayurveda's traditional use of Brahmi for children — classically given with warm milk to support cognitive development and focus in young students.
Brahmi's classical use for insomnia is supported by both its CNS-calming mechanisms and clinical data. The 2024 MDPI systematic review identified improvements in sleep routine among included studies, consistent with Brahmi's serotonergic and GABA-modulatory activity. 4 This makes Brahmi particularly relevant as a component of SupaSleep — its cortisol-lowering and anxiolytic effects address a root cause of stress-related insomnia, while its gentle cholinergic action may improve sleep architecture by supporting the acetylcholine-dependent mechanisms of REM sleep. Importantly, Brahmi does not cause daytime sedation at standard doses — its anxiolytic effects occur without impairing wakefulness, distinguishing it from sedative herbs. 2
Brahmi's antioxidant action in the brain has been extensively documented preclinically and forms a mechanistic bridge between its cognitive and neuroprotective effects. Studies confirm significant elevations in superoxide dismutase (SOD), catalase, and glutathione levels in the frontal cortex, striatum, and hippocampus following Brahmi administration. 11 The Nrf2 activation pathway — through which Brahmi upregulates the body's intrinsic antioxidant response — is considered mechanistically central. 4 Anti-inflammatory effects are mediated through NF-κB inhibition, reduced prostaglandin synthesis, and direct suppression of pro-inflammatory cytokines including TNF-α and IL-6. Together, these properties make Brahmi an important herb not only for acute cognitive support but also for long-term protection of brain health against the oxidative and inflammatory damage associated with ageing.
The Clinical Evidence at a Glance
The meta-analysis published in the Journal of Ethnopharmacology (Kongkeaw et al., 2014) represents the most rigorous quantitative synthesis of Brahmi's cognitive RCT data to date — pooling results from nine randomised, placebo-controlled trials in human subjects. 5
Meta-Analysis of RCTs — Cognitive Effects of Brahmi (Kongkeaw et al., 2014)
The meta-analysis confirmed statistically significant improvements in speed of attention as the most consistent finding across all studies. Memory consolidation, learning rate, and delayed recall also showed positive trends across multiple individual trials. The authors noted that a large head-to-head trial against an existing medication would be the next step to definitively establish efficacy. 5 Importantly, no adverse effects were reported in any of the included studies — consistent with Brahmi's well-established safety profile.
Traditional Use & Modern Dosage
Brahmi is one of Ayurveda's most versatile cognitive herbs and can be taken in multiple forms. The most important dosage principle — echoed by both classical texts and clinical research — is consistency over time. Brahmi's effects are cumulative, built through regular use over weeks rather than immediate action.
| Form | Traditional Preparation | Typical Dose (Adult) |
|---|---|---|
| Powder (Churna) | Dried whole herb ground; mixed with warm milk, ghee & honey — the classical Brahmi Ksheerapaka | 1–3 g/day in 1–2 divided doses |
| Capsules (Standardised Extract) | Standardised to 20–55% bacosides; most clinically studied form | 300–450 mg/day; follow product guidance |
| Medicated Ghee (Brahmi Ghrita) | Classical preparation: herb cooked into ghee for neurological & memory use; the fat matrix enhances bacoside absorption | 1–2 tsp daily in warm milk |
| Fresh Juice (Swarasa) | Fresh leaves blended and pressed; consumed directly or added to buttermilk | 10–20 ml once or twice daily |
| Decoction (Kwath) | Dried herb simmered in water; strained and consumed before meals | 20–40 ml twice daily |
The most clinically validated dose is 300 mg/day of a standardised extract (20–55% bacosides), administered consistently for a minimum of 12 weeks. Brahmi is traditionally taken in the morning with warm milk and ghee for cognitive use, and in the evening with warm milk for sleep support. A rest period of 2–4 weeks after each 8–12 week cycle is recommended in classical practice, though the evidence for this specific cycling is based on tradition rather than clinical data.
Supaveda Products with Brahmi
Brahmi features in three of our Ayurvedic formulas — each targeting a different aspect of the herb's remarkable therapeutic range:
An organic blend of Brahmi (Bacopa monnieri), Gotu Kola (Centella asiatica), and Vacha (Acorus calamus) — Ayurveda's three foremost Medhya Rasayana herbs, combined exactly as classical texts prescribed them: together, for synergistic support of memory, concentration, and mental clarity.
An organic blend of Brahmi, Tagar (Valeriana wallichii), and Manuka (Indian grape/raisin). Brahmi's cortisol-lowering and serotonergic activity addresses stress-related insomnia from the root — calming mental activity without daytime sedation — while Tagar relaxes the nervous system and Manuka contributes naturally occurring melatonin.
Our organic, vegan take on the 3,000-year-old Chyawanprash formula — 16 Ayurvedic herbs including Brahmi in a base of jaggery and coconut oil. Brahmi's inclusion in Chyawanprash reflects its classical role as a general Rasayana tonic: supporting cognitive vitality, nervous system health, and overall longevity as part of a comprehensive daily wellness formula.
Safety & Precautions
Brahmi has a high therapeutic index and is consistently well-tolerated in clinical studies. No serious adverse effects have been reported in any of the RCTs included in the 2014 meta-analysis or the 2024 systematic review. 54 The following precautions apply:
Please note
- Gastrointestinal effects: The most commonly reported side effects are mild GI symptoms — nausea, increased stool frequency, abdominal cramps — particularly at higher doses or when taken without food. Always take with food or warm milk to minimise this. 2
- Onset of effects: Brahmi is a slow-acting tonic herb. Most clinical benefits emerge after 4–8 weeks of consistent use; do not discontinue early if immediate effects are not felt.
- Pregnancy & breastfeeding: Insufficient human safety data for therapeutic doses during pregnancy — use only under professional guidance.
- Thyroid medications: One preclinical study suggested possible interaction with thyroid hormones — those on thyroid medication should consult a healthcare provider before use.
- Sedative medications: Brahmi has mild CNS-calming properties; use with caution alongside sedative medications, particularly at higher doses.
- CYP450 enzyme interactions: In vitro data suggest possible inhibition of certain liver enzymes — those on medications with narrow therapeutic windows should seek medical advice before use. 2
Key Takeaways
Evidence-backed bullet points:
Used in Ayurveda for over 3,000 years as a Medhya Rasayana — the tradition's highest classification for brain-supporting herbs
Named after Brahman — the Hindu concept of supreme consciousness — reflecting ancient recognition of its profound effects on the mind
Meta-analysis of 9 RCTs: significant improvement in speed of attention in healthy adults — with no adverse effects across all included studies
Described clinically as a "calming cognitive enhancer" — uniquely improves mental performance while reducing anxiety and stress
RCT in adults aged 65+: significantly reduced anxiety and depression alongside improved cognitive performance in 12 weeks
Double-blind RCT in 125 boys (6–14 yrs): significant cognitive improvement for attention and hyperactivity over 24 weeks
Inhibits acetylcholinesterase — the enzyme that breaks down your memory neurotransmitter — a mechanism shared with pharmaceutical dementia drugs
Reduces β-amyloid formation and tau phosphorylation in Alzheimer's models — neuroprotection that operates years before symptoms appear
Improves sleep quality via serotonin and GABA modulation — reduces stress-induced insomnia without causing daytime sedation
Takes 4–8 weeks to build effect — unlike stimulants, Brahmi is a tonic that restores cognitive capacity over time, not overnight
References
- Walker, E.A. and Pellegrini, M.V. (2023) 'Bacopa monnieri', in StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. Available at: https://www.ncbi.nlm.nih.gov/books/NBK589635/. PMC NBK589635. [Updated 17 March 2023].
- Russo, A. and Borrelli, F. (2005) 'Bacopa monniera, a reputed nootropic plant: an overview', Phytomedicine, 12(4), pp.305–317. doi: 10.1016/j.phymed.2003.12.008. PMID: 15898709.
- Aguiar, S. and Borowski, T. (2013) 'Neuropharmacological review of the nootropic herb Bacopa monnieri', Rejuvenation Research, 16(4), pp.313–326. doi: 10.1089/rej.2013.1431. PMC3746283.
- Santos, B.M., Lôbo, I.L., Ferrari, G., Ortega, M.A. and Bueno-Hernández, N. (2024) 'Investigating the neuroprotective and cognitive-enhancing effects of Bacopa monnieri: a systematic review focused on inflammation, oxidative stress, mitochondrial dysfunction, and apoptosis', Antioxidants, 13(4), p.393. doi: 10.3390/antiox13040393. PMC11047749.
- Kongkeaw, C., Dilokthornsakul, P., Thanarangsarit, P., Limpeanchob, N. and Scholfield, C.N. (2014) 'Meta-analysis of randomized controlled trials on cognitive effects of Bacopa monnieri extract', Journal of Ethnopharmacology, 151(1), pp.528–535. doi: 10.1016/j.jep.2013.11.008. PMID: 24252493.
- Stough, C., Lloyd, J., Clarke, J., Downey, L.A., Hutchison, C.W., Rodgers, T. and Nathan, P.J. (2001) 'The chronic effects of an extract of Bacopa monniera (Brahmi) on cognitive function in healthy human subjects', Psychopharmacology, 156(4), pp.481–484. doi: 10.1007/s002130100815. PMID: 11498727.
- Morgan, A. and Stevens, J. (2010) 'Does Bacopa monnieri improve memory performance in older persons? Results of a randomized, placebo-controlled, double-blind trial', Journal of Alternative and Complementary Medicine, 16(7), pp.753–759. doi: 10.1089/acm.2009.0342. PMID: 20590480.
- Calabrese, C., Gregory, W.L., Leo, M., Kraemer, D., Bone, K. and Oken, B. (2008) 'Effects of a standardized Bacopa monnieri extract on cognitive performance, anxiety, and depression in the elderly: a randomized, double-blind, placebo-controlled trial', Journal of Alternative and Complementary Medicine, 14(6), pp.707–713. doi: 10.1089/acm.2008.0018. PMC3153866.
- Basheer, A., Agarwal, A., Mishra, B., Gupta, A., Padma Srivastava, M.V., Kirubakaran, R. and Vishnu, V. (2022) 'Use of Bacopa monnieri in the treatment of dementia due to Alzheimer disease: systematic review of randomized controlled trials', Interactive Journal of Medical Research, 11(2), e38542. doi: 10.2196/38542. PMC9382540.
- Kean, J.D., Downey, L.A., Sarris, J., Kaufman, J., Zangara, A. and Stough, C. (2022) 'Effects of Bacopa monnieri (CDRI 08) in a population of males exhibiting inattention and hyperactivity aged 6 to 14 years: a randomized, double-blind, placebo-controlled trial', Phytotherapy Research, 36(2), pp.996–1012. doi: 10.1002/ptr.7310. PMID: 34967056.
- Bhattacharya, S.K., Bhattacharya, A., Kumar, A. and Ghosal, S. (2000) 'Antioxidant activity of Bacopa monniera in rat frontal cortex, striatum and hippocampus', Phytotherapy Research, 14(3), pp.174–179. doi: 10.1002/(SICI)1099-1573(200005)14:3<174::AID-PTR573>3.0.CO;2-H. PMID: 10815004.
- Lopresti, A.L. and Smith, S.J. (2025) 'The effects of a Bacopa monnieri extract (Bacumen®) on cognition, stress, and fatigue in healthy adults: a randomized, double-blind, placebo-controlled trial', Clinical Drug Investigation, 45(12), pp.967–982. doi: 10.1007/s40261-025-01418-3. [Most recent RCT as of March 2026].